New Strong Buy Stocks Apr 2026

: Labeled a "biotech breakout" by Citigroup with a maximum 1-year forecast of $242 , implying a potential 89% upside .

: Recently upgraded to Outperform by Bernstein with a $358 target . The removal of regulatory "overhangs" has led to a consensus Strong Buy rating from 13 different analysts. 📊 Quantitative "Strong Buy" Additions (Zacks Rank #1) new strong buy stocks

As of late April 2026, several high-conviction "Strong Buy" ratings have emerged across the pharmaceutical, technology, and energy sectors, driven by record earnings beats and significant analyst price target upgrades. 🚀 Top Analyst Conviction Picks : Labeled a "biotech breakout" by Citigroup with